FDA Drug Recalls

Recalls / Class II

Class IID-033-2013

Product

Doxazosin Tablets, USP, 2 mg, 100 count bottles, labeled in part ***Manufactured in Australia by: ALPHAPHARM PTY LTD, 15 Garnet Street***Rx Only*** Carole Park QLD 4300, Australia*** Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.SA ***

Affected lot / code info
Lot A 303M, Exp. June 2014

Why it was recalled

Cross Contamination w/Other Products: During stability testing chromatographic review revealed extraneous peaks identified as acetaminophen and codeine.

Recalling firm

Firm
Mylan Pharmaceuticals Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
781 Chestnut Ridge Rd, N/A, Morgantown, West Virginia 26505-2730

Distribution

Quantity
24,331 bottles
Distribution pattern
Nationwide.

Timeline

Recall initiated
2012-08-07
FDA classified
2012-10-25
Posted by FDA
2012-10-31
Terminated
2013-03-27
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-033-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.